Impact of Lesion Placement on Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation

被引:165
作者
Mahfoud, Felix [1 ]
Tunev, Stefan [2 ]
Ewen, Sebastian [1 ]
Cremers, Bodo [1 ]
Ruwart, Jennifer [2 ]
Schulz-Jander, Daniel [2 ]
Linz, Dominik [1 ]
Davies, Justin [3 ]
Kandzari, David E. [4 ]
Whitbourn, Robert [5 ]
Boehm, Michael [1 ]
Melder, Robert J. [2 ]
机构
[1] Univ Klinikum Saarlandes, Innere Med Klin 3, D-66421 Homburg, Germany
[2] Medtron Cardiovasc, Santa Rosa, CA USA
[3] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Int Ctr Circulatory Hlth, London, England
[4] Piedmont Heart Inst, Atlanta, GA USA
[5] St Vincents Hosp, Cardiovasc Res Ctr, Melbourne, Vic, Australia
关键词
branch treatment; optimized techniques; resistant hypertension; TREATMENT-RESISTANT HYPERTENSION; BLOOD-PRESSURE RESPONSE; SYMPATHETIC DENERVATION; CONTROLLED-TRIAL; NERVES; MATTER;
D O I
10.1016/j.jacc.2015.08.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Insufficient procedural efficacy has been proposed to explain nonresponse to renal denervation (RDN). OBJECTIVES The aim of this study was to examine the impact of different patterns of lesion placements on the efficacy and consistency of catheter-based radiofrequency RDN in pigs. METHODS The impact of increasing number of lesions versus location of RDN was investigated in a porcine model (Group 1; n = 51). The effect of treating the main artery, the branches, and the 2 combined was compared in Group 2 (n = 48). The durability of response and safety of combined treatment of the main artery plus branches was examined in Group 3 (n = 16). Renal norepinephrine (NE) tissue content and renal cortical axon density were assessed. RESULTS Increasing the number of RF lesions (4, 8, and 12) in the main renal artery was not sufficient to yield a clear dose-response relationship on NE content and axon density. In contrast, targeted treatment of the renal artery branches or distal segment of the main renal artery resulted in markedly less variability of response and significantly greater reduction of both NE and axon density than conventional treatment of only the main renal artery. Combination treatment (main artery plus branches) produced the greatest change in renal NE and axon density with the least heterogeneity. The changes were durable through 28 days post-treatment. CONCLUSIONS These data provide the rationale for investigation of an optimized approach for RDN in future clinical studies. This may have profound implications for the clinical application of RDN, as this approach may not only achieve greater reductions in sympathetic activity but also reduce treatment effect variability. (C) 2015 by the American College of Cardiology Foundation.
引用
收藏
页码:1766 / 1775
页数:10
相关论文
共 31 条
  • [1] Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial
    Azizi, Michel
    Sapoval, Marc
    Gosse, Philippe
    Monge, Matthieu
    Bobrie, Guillaume
    Delsart, Pascal
    Midulla, Marco
    Mounier-Vehier, Claire
    Courand, Pierre-Yves
    Lantelme, Pierre
    Denolle, Thierry
    Dourmap-Collas, Caroline
    Trillaud, Herve
    Pereira, Helena
    Plouin, Pierre-Francois
    Chatellier, Gilles
    [J]. LANCET, 2015, 385 (9981) : 1957 - 1965
  • [2] A Controlled Trial of Renal Denervation for Resistant Hypertension
    Bhatt, Deepak L.
    Kandzari, David E.
    O'Neill, William W.
    D'Agostino, Ralph
    Flack, John M.
    Katzen, Barry T.
    Leon, Martin B.
    Liu, Minglei
    Mauri, Laura
    Negoita, Manuela
    Cohen, Sidney A.
    Oparil, Suzanne
    Rocha-Singh, Krishna
    Townsend, Raymond R.
    Bakris, George L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (15) : 1393 - 1401
  • [3] First Report of the Global SYMPLICITY Registry on the Effect of Renal Artery Denervation in Patients With Uncontrolled Hypertension
    Boehm, Michael
    Mahfoud, Felix
    Ukena, Christian
    Hoppe, Uta C.
    Narkiewicz, Krzysztof
    Negoita, Manuela
    Ruilope, Luis
    Schlaich, Markus P.
    Schmieder, Roland E.
    Whitbourn, Robert
    Williams, Bryan
    Zeymer, Uwe
    Zirlik, Andreas
    Mancia, Giuseppe
    [J]. HYPERTENSION, 2015, 65 (04) : 766 - +
  • [4] Renal Denervation for the Treatment of Cardiovascular High Risk-Hypertension or Beyond?
    Boehm, Michael
    Linz, Dominik
    Ukena, Christian
    Esler, Murray
    Mahfoud, Felix
    [J]. CIRCULATION RESEARCH, 2014, 115 (03) : 400 - 409
  • [5] Reinnervation of Renal Afferent and Efferent Nerves at 5.5 and 11 Months After Catheter-Based Radiofrequency Renal Denervation In Sheep
    Booth, Lindsea C.
    Nishi, Erika E.
    Yao, Song T.
    Ramchandra, Rohit
    Lambert, Gavin W.
    Schlaich, Markus P.
    May, Clive N.
    [J]. HYPERTENSION, 2015, 65 (02) : 393 - U308
  • [6] Randomized Sham-Controlled Trial of Renal Sympathetic Denervation in Mild Resistant Hypertension
    Desch, Steffen
    Okon, Thomas
    Heinemann, Diana
    Kulle, Konrad
    Roehnert, Karoline
    Sonnabend, Melanie
    Petzold, Martin
    Mueller, Ulrike
    Schuler, Gerhard
    Eitel, Ingo
    Thiele, Holger
    Lurz, Philipp
    [J]. HYPERTENSION, 2015, 65 (06) : 1202 - 1208
  • [7] Physiology in perspective:: The Wisdom of the Body.: Neural control of the kidney
    DiBona, GF
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2005, 289 (03) : R633 - R641
  • [8] The sympathetic system and hypertension
    Esler, M
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2000, 13 (06) : 99S - 105S
  • [9] Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings
    Esler, Murray
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2014, 8 (08) : 593 - 598
  • [10] The 2009 Carl Ludwig Lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management
    Esler, Murray
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2010, 108 (02) : 227 - 237